Xiang-jin Zheng

发表

Network pharmacology study of traditional Chinese medicines for stroke treatment and effective constituents screening.

Li-wen Ren, Xiang-jin Zheng, Jin-yi Liu, 2019, Journal of ethnopharmacology.

GABRP is a potential prognostic biomarker and correlated with immune infiltration and tumor microenvironment in pancreatic cancer

Li-wen Ren, Xiang-jin Zheng, Jin-yi Liu, 2021, Translational cancer research.

Epigenetic hypomethylation and upregulation of GD3s in triple negative breast cancer.

Li-wen Ren, Xiang-jin Zheng, Jin-yi Liu, 2019, Annals of translational medicine.

Research progress on the forkhead box C1

Xiang-jin Zheng, Wan Li, Jinhua Wang, 2017, Oncotarget.

Anti-tumor Effects of Skp2 Inhibitor AAA-237 on NSCLC by Arresting Cell Cycle at G0/G1 Phase and Inducing Senescence.

Han Yang, Li-wen Ren, Xiang-jin Zheng, 2022, Pharmacological research.

Apolipoprotein C1 promotes glioblastoma tumorigenesis by reducing KEAP1/NRF2 and CBS-regulated ferroptosis

Han Yang, J. Yi, Wenlin Chen, 2022, Acta Pharmacologica Sinica.

Avasimibe exerts anticancer effects on human glioblastoma cells via inducing cell apoptosis and cell cycle arrest

Li-wen Ren, Xiang-jin Zheng, Jin-yi Liu, 2020, Acta Pharmacologica Sinica.

Apolipoprotein C1 (APOC1) as a novel diagnostic and prognostic biomarker for gastric cancer.

Jie Wu, J. Yi, Li-wen Ren, 2019, Annals of translational medicine.

Systematic pan-cancer analysis identifies APOC1 as an immunological biomarker which regulates macrophage polarization and promotes tumor metastasis.

Han Yang, Xifu Wang, J. Yi, 2022, Pharmacological research.

CDK1 serves as a therapeutic target of adrenocortical carcinoma via regulating epithelial–mesenchymal transition, G2/M phase transition, and PANoptosis

Han Yang, Li-wen Ren, Xiang-jin Zheng, 2022, Journal of Translational Medicine.

Sinomenine ester derivative inhibits glioblastoma by inducing mitochondria-dependent apoptosis and autophagy by PI3K/AKT/mTOR and AMPK/mTOR pathway

Tengfei Ji, Li-wen Ren, Xiang-jin Zheng, 2021, Acta pharmaceutica Sinica. B.

Sphingosine kinase 1 promotes growth of glioblastoma by increasing inflammation mediated by the NF-κB /IL-6/STAT3 and JNK/PTX3 pathways

Han Yang, Li-wen Ren, Xiang-jin Zheng, 2022, Acta pharmaceutica Sinica. B.

The sphingosine kinase‐1/sphingosine‐1‐phosphate axis in cancer: Potential target for anticancer therapy

Xiuping Chen, Li-wen Ren, Xiang-jin Zheng, 2019, Pharmacology & therapeutics.

Author Correction: Apolipoprotein C1 promotes glioblastoma tumorigenesis by reducing KEAP1/NRF2 and CBS-regulated ferroptosis

Han Yang, J. Yi, Wenlin Chen, 2022, Acta Pharmacologica Sinica.

Tumorigenic bacteria in colorectal cancer: mechanisms and treatments

Li-wen Ren, Xiang-jin Zheng, Jin-yi Liu, 2021, Cancer biology & medicine.

Withaferin A triggers G2/M arrest and intrinsic apoptosis in glioblastoma cells via ATF4‐ATF3‐CHOP axis

Li-wen Ren, Xiang-jin Zheng, Jin-yi Liu, 2019, Cell proliferation.

Members of FOX family could be drug targets of cancers

Xiang-jin Zheng, Wan Li, Jinhua Wang, 2018, Pharmacology & therapeutics.

miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway

D. Hoon, J. Yi, Li-wen Ren, 2018, Clinical Epigenetics.

1-1-2018 miR-29 c plays a suppressive role in breast cancer by targeting the TIMP 3 / STAT 1 / FOXO 1 pathway

D. Hoon, J. Yi, Li-wen Ren, 2018 .

3-O-acetyl-11-keto-β-boswellic acid exerts anti-tumor effects in glioblastoma by arresting cell cycle at G2/M phase

Tengfei Ji, Li-wen Ren, Xiang-jin Zheng, 2018, Journal of Experimental & Clinical Cancer Research.

Benzimidazoles induce concurrent apoptosis and pyroptosis of human glioblastoma cells via arresting cell cycle

Li-wen Ren, Xiang-jin Zheng, Jin-yi Liu, 2021, Acta Pharmacologica Sinica.

Benzimidazoles induce concurrent apoptosis and pyroptosis of human glioblastoma cells via arresting cell cycle

Sen Zhang, Li-wen Ren, Xiang-jin Zheng, 2021, Acta Pharmacologica Sinica.

A narrative review of research progress on drug therapies for glioblastoma multiforme

Li-wen Ren, Xiang-jin Zheng, Jin-yi Liu, 2021, Annals of translational medicine.

Avasimibe exerts anticancer effects on human glioblastoma cells via inducing cell apoptosis and cell cycle arrest

Li-wen Ren, Xiang-jin Zheng, Jin-yi Liu, 2020, Acta Pharmacologica Sinica.

Apolipoproteins and cancer

J. Yi, Li-wen Ren, Xiang-jin Zheng, 2019, Cancer medicine.

3-O-Acetyl-11-keto-β-boswellic acid ameliorated aberrant metabolic landscape and inhibited autophagy in glioblastoma

G. Du, Tengfei Ji, Li-wen Ren, 2020, Acta pharmaceutica Sinica. B.

EZH2 regulates expression of FOXC1 by mediating H3K27me3 in breast cancers

J. Yi, Li-wen Ren, Xiang-jin Zheng, 2020, Acta Pharmacologica Sinica.

The biology, function, and applications of exosomes in cancer

J. Yi, Li-wen Ren, Xiang-jin Zheng, 2021, Acta pharmaceutica Sinica. B.

MELK is an oncogenic kinase essential for metastasis, mitotic progression, and programmed death in lung carcinoma

Li-wen Ren, Xiang-jin Zheng, Jin-yi Liu, 2020, Signal Transduction and Targeted Therapy.

miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway

D. Hoon, J. Yi, Li-wen Ren, 2018, Clinical Epigenetics.

Ganglioside GD3 synthase (GD3S), a novel cancer drug target

G. Du, Xiang-jin Zheng, Jin-yi Liu, 2018, Acta pharmaceutica Sinica. B.

ADH1C inhibits progression of colorectal cancer through the ADH1C/PHGDH /PSAT1/serine metabolic pathway

Han Yang, Li-wen Ren, Xiang-jin Zheng, 2022, Acta Pharmacologica Sinica.

Progress on diagnostic and prognostic markers of pancreatic cancer

Han Yang, Li-wen Ren, Xiang-jin Zheng, 2023, Oncology research.

3-O-acetyl-11-keto-β-boswellic acid exerts anti-tumor effects in glioblastoma by arresting cell cycle at G2/M phase

Tengfei Ji, Li-wen Ren, Xiang-jin Zheng, 2018, Journal of experimental & clinical cancer research : CR.

Correction: 3-O-acetyl-11-keto-β-boswellic acid exerts anti-tumor effects in glioblastoma by arresting cell cycle at G2/M phase

Li-wen Ren, Xiang-jin Zheng, Jin-yi Liu, 2022, Journal of experimental & clinical cancer research : CR.